View in EDS HTML Full Text PDF Full Text

Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.

Saved in:
Bibliographic Details
Title: Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.
Authors: Yang, Tsai‐Sheng1 (AUTHOR), Chen, Hong‐Hwa2 (AUTHOR), Bo‐Wen, Lin3 (AUTHOR), Kim, Tae Won4 (AUTHOR), Kim, Jong Gwang5 (AUTHOR), Ahn, Joong Bae6 (AUTHOR), Lee, Myung‐Ah7 (AUTHOR), Lin, Johnson8 (AUTHOR), Ho, Gwo Fuang9 (AUTHOR), Anh, Le Tuan10 (AUTHOR), Temraz, Sally11 (AUTHOR), Burge, Matthew12 (AUTHOR), Chua, Clarinda13 (AUTHOR), Huang, Jason14 (AUTHOR), Park, Young Suk15 (AUTHOR) pys27hmo@skku.edu
Source: Asia Pacific Journal of Clinical Oncology. Dec2023, Vol. 19 Issue 6, p672-680. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17437555
DOI:10.1111/ajco.13920